ICAM1 and esophageal squamous cell carcinoma: Our investigation showed the presence of ICAM1 contributes to cancer cell sphere formation, drug resistance, and tumorigenesis in mouse xenotransplantation model, indicating that ICAM1 can be used as a potential CSC marker of ESCC and therefore serve as a therapeutic target for drug design and development.